Loren Beek
Optometrist · Independence, MONPI 1114984390
Payments from drug & device makers
Across 36 payments — averaging $115.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- ABB Con-cise Optical Group LLC$1K
- Coopervision Inc.$310
- Bausch & Lomb Americas Inc.$262
- Alcon$224
- Synergeyes, Inc.$177
- plus $330 from 4 others
What the payments were for
- Consulting fees$1,00024%
- Travel & lodging$1,69941%
- Food & beverage$1,45535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $1,737 |
| ABB Con-cise Optical Group LLC | 3 | $1,114 |
| Coopervision Inc. | 9 | $310 |
| Bausch & Lomb Americas Inc. | 3 | $262 |
| Alcon | 3 | $224 |
| Synergeyes, Inc. | 2 | $177 |
| Biotissue Holdings Inc. | 2 | $168 |
| Tarsus Pharmaceuticals, Inc. | 1 | $121 |
| Dompe US, Inc. | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOTRUE$1,394
- ULTRA$1,394
- Contact Lens$1,000
- INFUSE$125
- XDEMVY$121
- TOTAL30$120
- Onefit Contact Lens$102
How this compares
$4,154 in reported general payments places this provider in the 85th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 27 | $25,838 |
| Cyclosporine | 11 | $11,721 |
| Latanoprost | 177 | $2,658 |
| Prednisolone Acetate | 31 | $943 |
| Dorzolamide Hcl | 21 | $859 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 44 | $849 |
| Brimonidine Tartrate | 38 | $520 |
| Timolol Maleate | 49 | $509 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 35 | $449 |
| MoxifloxacinMoxifloxacin Hcl | 13 | $291 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 14 | $137 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Independence
- Jessica HillnerIndependence$11K
- Anthony VerachtertKansas City$959K
- Joseph CastellanoSaint Louis$369K
- Richard WilsonRaytown$355K
- Lawrence ReedRaytown$317K
- Andrew BiondoKirkwood$300K
- Nicholas CastellanoSaint Louis$171K
- Geoffrey PowellKansas City$154K
- John McGrealSaint Louis$126K
- Erin SullivanSaint Louis$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.